“streamlined, internationally competitive approach to the licensing and regulation of innovative medicines and devices, to give patients access to the best possible treatments and support the UK’s life sciences industry.”
Currently, most of the UK regulatory framework for drugs and devices is set by Brussels.
A lawsuit aiming to prevent the release of drug safety data threatens patients and public health across Europe, 31 patient and public health groups from across Europe warn in an open letter published today.
While universities in other countries are rapidly progressing in making their clinical trial results public, some universities in Germany still lag far behind.
Data from the EU Trials Tracker shows that the five worst performers in Europe are all German universities. Between them, these universities have sponsored 95 clinical trials that are due to post results onto the European...
In this guest blog, Marc Taylor, Chair of the ISRCTN clinical trial registry, explains how the registry actively contacts researchers to remind them to update trial data and report study results, and has worked to make trial registration and reporting easier for users. ISRCTN is currently seeking feedback on how to further improve its services.
The Association of the British Pharmaceutical Industry (ABPI) identifies “high standards for transparency” as one of seven key factors required to maintain the UK’s position as an "attractive destination for global investment in the sector".
Irish medical schools have made the results of over 85% of their clinical trials available on the European trial registry, making Irish universities the strongest transparency performers in the whole of Europe.
Irish universities’ reporting rate of 85.7% places it ahead of academic institutions in the UK, which have uploaded the results of 72.1% of their trials. In contrast, les...
Evidence requirements and transparency of evidence for medical devices will probably improve under the incoming EU Medical Device Regulation, but will continue to fall short of the standards applied to medicines, a paper published by the British charity HealthWatch has found.
Issues covered in the paper:
Strengths and weaknesses of the Medical Device Regulation
The European Medicines Agency has announced plans to make it easier for universities and smaller pharma companies to upload the results of clinical trials of medicines onto the European trial registry EudraCT.
Posting results of onto the registry has been mandatory since 2014, but many institutions running clinical trials are violating this transparency rule, leaving large gaps...
On Tuesday, UK parliament will assess progress in clinical trial reporting by universities and NHS Trusts. The session follows up on parliament’s 2018 enquiry into clinical trial transparency, and will be streamed live from 09:30 onwards.